The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beaulieu, S.
Right arrow Articles by Mojsov, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beaulieu, S.
Right arrow Articles by Mojsov, S.
The Journal of Immunology, 2002, 169: 2925-2936.
Copyright © 2002 by The American Association of Immunologists

Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells1 ,2 ,3

Sylvie Beaulieu4,*, Davide F. Robbiani*, Xixuan Du*, Elaine Rodrigues{dagger}, Ralf Ignatius5,*, Yang Wei*, Paul Ponath6,{ddagger}, James W. Young{dagger}, Melissa Pope7,*, Ralph M. Steinman* and Svetlana Mojsov8,*

* Laboratory of Cellular Physiology and Immunology, The Rockefeller University and {dagger} Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College, Cornell University, New York, NY 10021; and {ddagger} LeukoSite, Cambridge, MA 02139

Critical to the function of Ag-presenting dendritic cells (DCs) is their capacity to migrate to lymphoid organs and to sites of inflammation. A final stage of development, termed maturation, yields DCs that are strong stimulators of T cell-mediated immunity and is associated with a remodeling of the cell surface that includes a change in the levels of expression of many molecules, including chemokine receptors. We show in this study that CCR3, a chemokine receptor initially discovered on eosinophils, is also expressed by human DCs that differentiate from blood monocytes, DCs that emigrate from skin (epidermal and dermal DCs), and DCs derived from CD34+ hemopoietic precursors in bone marrow, umbilical cord blood, and cytokine-elicited peripheral blood leukapheresis. Unlike other chemokine receptors, such as CCR5 and CCR7, the expression of CCR3 is not dependent on the state of maturation. All DC subsets contain a large intracellular pool of CCR3. The surface expression of CCR3 is not modulated following uptake of particulate substances such as zymosan or latex beads. CCR3 mediates in vitro chemotactic responses to the known ligands, eotaxin and eotaxin-2, because the DC response to these chemokines is inhibited by CCR3-specific mAbs. We postulate that expression of CCR3 may underlie situations where both DCs and eosinophils accumulate in vivo, such as the lesions of patients with Langerhans cell granulomatosis.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
N. J. Stevenson, M. R. Addley, E. J. Ryan, C. R. Boyd, H. P. Carroll, V. Paunovic, C. A. Bursill, H. C. Miller, K. M. Channon, A. E. McClurg, et al.
CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression
J. Leukoc. Biol., February 1, 2009; 85(2): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Main, R. Handy, J. Wilton, S. Smith, L. Williams, L. D. Fou, J. Andrews, L. A. Conroy, R. May, I. Anderson, et al.
A Potent Human Anti-Eotaxin1 Antibody, CAT-213: Isolation by Phage Display and in Vitro and in Vivo Efficacy
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan
Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis
Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Z. Liu, V. Dvornyk, Y. Lu, H. Shen, J. M. Lappe, R. R. Recker, and H.-W. Deng
A Novel Pathophysiological Mechanism for Osteoporosis Suggested by an in Vivo Gene Expression Study of Circulating Monocytes
J. Biol. Chem., August 12, 2005; 280(32): 29011 - 29016.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. L. Chou, B. L. Daugherty, E. K. McKenna, W. M. Hsu, N. K. Tyler, C. G. Plopper, D. M. Hyde, E. S. Schelegle, L. J. Gershwin, and L. A. Miller
Chronic Aeroallergen during Infancy Enhances Eotaxin-3 Expression in Airway Epithelium and Nerves
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. B. Kodali, W. J.H. Kim, I. I. Galaria, C. Miller, A. D. Schecter, S. A. Lira, and M. B. Taubman
CCL11 (Eotaxin) Induces CCR3-Dependent Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1211 - 1216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Jinquan, H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al.
CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells
J. Immunol., August 15, 2003; 171(4): 1722 - 1731.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. D. Shin, L. H. Kim, B. L. Park, J. H. Jung, J. Y. Kim, I.-Y. Chung, J. S. Kim, J. H. Lee, S. H. Chung, Y. H. Kim, et al.
Association of Eotaxin gene family with asthma and serum total IgE
Hum. Mol. Genet., June 1, 2003; 12(11): 1279 - 1285.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.